Is Viemed Healthcare, Inc. (VMD) Overvalued?
We dive into why Viemed Healthcare, Inc. (VMD) could be considered overvalued on 2026-08-17, based on AAII’s Value Score and Grade.Jenna Brashear
| SECTOR | INDUSTRY |
| Health Care | Health Care Providers & Services |
A+ Stock Grade Summary:
| VALUE: |
|
|
| GROWTH: |
|
|
| MOMENTUM: |
|
|
| EPS REVISIONS: |
|
|
| QUALITY: |
|
|
Jenna Brashear
Michael Rose
Jenna Brashear
Michael Rose
Jenna Brashear
| Share Statistics | VMD | Industry Median |
Percentile (All Stocks) |
|
| Market Cap (Mil) | $335.2 | $1,693.8 | 33% |
|
| Shares Out (Mil) | 41.1 | 77.7 | 43% |
|
| Institutional Ownership | 81.8% | 87.7% | 50% |
|
| Float (Mil) | 30.6 | 55.7 | 36% |
|
| Beta | 1.12 | 0.81 | 67% |
|
| Avg Daily Volume (000s) | 264 | 655 | 46% |
|
| Price Change (52-week) |
27.0% | 77.8% | 73% |
|
| Growth | VMD | Industry Median |
Percentile (All Stocks) |
|
| Sales (5yr) | 15.5% | 10.6% | 74% |
|
| Net Income (5yr) | (13.9%) | (0.3%) | 26% |
|
| EPS (5yr) | (13.9%) | 3.0% | 19 |
|
| Dividends (5yr) | 0.0% | 0.0% | 0% |
|
| Cash Flow (5yr) | (17.3%) | (17.7%) | 41% |
|
| Estimates | Qtrly | Current Fiscal Year |
Next Fiscal Year |
|
| # of Estimates | na | na | na | |
| Current EPS | na | na | na | |
| Month Ago EPS | na | na | na | |
| # Rev Up | na | na | na | |
| # Rev Down | na | na | na | |
| Three Months Ago EPS | na | na | na | |
| Year/Year Chg | na | na | na | |
| Financials | VMD | Industry Median |
Percentile (All Stocks) |
|
| Sales (TTM) (Mil) | $302 | $1,505 | 36% |
|
| Net Income (TTM) (Mil) | $15 | $26 | 47% |
|
| EPS (TTM) | $0.378 | $0.200 | 51% |
|
| Operating Cash Flow (TTM) (Mil) | $61 | $157 | 48% |
|
| Net Cash Flow (TTM) (Mil) | ($9) | $7 | 31% |
|
| Long-Term Debt (Q1) (Mil) | $10 | $374 | 28% |
|
| Enterprise Value (Q1) (Mil) | $378 | $2,284 | 31% |
|
| Valuation | VMD | Industry Median |
Percentile (All Stocks) |
|
| P/B | 2.33 | 2.90 | 57% |
|
| P/E | 24.4 | 24.8 | 63% |
|
| Dividend Yield | 0.0% | 0.0% | 0% |
|
| PEG (5yr hist) | na | 1.1 | na |
|
| Ratios | VMD | Industry Median |
Percentile (All Stocks) |
|
| Gross Margin | 57.5% | 27.6% | 70% |
|
| Net Margin | 4.8% | 1.2% | 47% |
|
| ROA | 7.5% | 2.1% | 81% |
|
| ROE | 10.2% | 6.8% | 57% |
|
| Liabilities to Assets | 28.5% | 61.3% | 20% |
|
| F-Score | 5 | 5 | 50% |
|
Viemed Healthcare, Inc. did not pass any screens on 9/23/2026.
Price and market data provided by QuoteMedia and delayed a minimum of 15 minutes unless otherwise indicated. Fundamental data provided by AAII's Stock Investor Pro and S&P Global Market Intelligence and are updated through the previous trading day.
Ⓒ 2026 American Association of Individual Investors